Expression of a Mutant (Arg 92 Gln) Human Cardiac Troponin T, Known to Cause Hypertrophic Cardiomyopathy, Impairs Adult Cardiac Myocyte Contractility
- 1 July 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 81 (1) , 76-85
- https://doi.org/10.1161/01.res.81.1.76
Abstract
The mechanism(s) by which mutations in sarcomeric proteins cause hypertrophic cardiomyopathy (HCM) remains unknown. A leading hypothesis proposes that mutant sarcomeric proteins impair cardiac myocyte contractility, providing an impetus for compensatory hypertrophy. To test this hypothesis, we determined the impact of expression of a mutant (Arg 92 Gln) human cardiac troponin T (cTnT), known to cause HCM in humans, on adult cardiac myocyte contractility. A full-length human cTnT cDNA was cloned, and the Arg 92 Gln mutation was induced. Recombinant adenoviruses Ad5/CMV/cTnT-N and Ad5/CMV/cTnT-Arg 92 Gln were generated through homologous recombination. Adult feline cardiac myocytes were infected with recombinant adenoviruses or a control viral vector (Ad5ΔE1) at a multiplicity of infection of 100. Expression levels of the full-length normal and mutant cTnT proteins were equal on Western blots. Expression of the exogenous cTnT proteins in cardiac myocytes was also shown by immunocytochemistry and immunofluorescence, and their incorporation into myofibrils was confirmed by Western blotting on myofibrillar extracts. Electron microscopy showed intact sarcomere structure in rod-shaped cardiac myocytes in all groups. Cell fractional shortening and the peak velocity of shortening were not significantly different among the groups 24 hours after transduction. However, 48 hours after transduction, both fractional shortening and the peak velocity of shortening were significantly reduced (24% [ P <.001] and 26% [ P <.001], respectively) in cardiac myocytes in the Ad5/CMV/cTnT-Arg 92 Gln compared with the Ad5/CMV/cTnT-N groups. The magnitude of the reductions was greater at 72 hours after transduction (45% and 39%, respectively; P <.001). Our results indicated that expression of the mutant (Arg 92 Gln) cTnT, known to cause HCM in humans, impaired intact adult cardiac myocyte contractility. Our data also show that both normal and mutant cTnT were incorporated into myofibrils. These results provide a potential mechanism by which mutations in sarcomeric proteins cause HCM.Keywords
This publication has 32 references indexed in Scilit:
- Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action.Journal of Clinical Investigation, 1996
- Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy.Journal of Clinical Investigation, 1996
- Developmental genetic analysis of troponin T mutations in striated and nonstriated muscle cells of Caenorhabditis elegans.The Journal of cell biology, 1996
- NH2-terminal Truncation of Skeletal Muscle Troponin T Does Not Alter the Ca2+ Sensitivity of Thin Filament AssemblyPublished by Elsevier ,1995
- Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.Journal of Clinical Investigation, 1995
- Thick filament substructures in Caenorhabditis elegans: evidence for two populations of paramyosin.The Journal of cell biology, 1993
- Molecular cloning and developmental expression of human cardiac troponin TFEBS Letters, 1993
- Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy.Journal of Clinical Investigation, 1992
- Drosophila melanogaster troponin-T mutations engender three distinct syndromes of myofibrillar abnormalitiesJournal of Molecular Biology, 1990
- A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutationPublished by Elsevier ,1990